Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Notices 35499 

Signed in Washington, DC, on June 30, 

2021. 

Treena V. Garrett, 

Federal Register Liaison Officer, U.S. 

Department of Energy. 

[FR Doc. 2021–14274 Filed 7–2–21; 8:45 am] 

BILLING CODE 6450–01–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2019–0578; FRL–10004– 

31] 

Approvals and Denials of Test 

Marketing Exemptions for Certain New 

Chemicals Under TSCA 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: This document provides 

notification of EPA’s approvals and 

denials of applications for test 

marketing exemptions (TMEs) 

submitted under the Toxic Substances 

Control Act (TSCA) for certain new 

chemicals. The test marketing 

conditions are described in the TME 

applications and in this document. 

FOR FURTHER INFORMATION CONTACT: For 

technical information contact: Meg 

Victor, New Chemicals Division 

(7405M), Office of Pollution Prevention 

and Toxics, Environmental Protection 

Agency, 1200 Pennsylvania Ave. NW, 

Washington, DC 20460–0001; telephone 

number: (202) 343–9193; email address: 

victor.meg@epa.gov. 

For general information contact: The 

TSCA-Hotline, ABVI-Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; email address: TSCA-Hotline@

epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action may be of interest to the 

chemical manufacturers and/or 

importers who submitted the TMEs to 

EPA and to the public in general. The 

Agency has not attempted to describe all 

the specific entities that may be affected 

by this action. 

B. How can I get copies of this document 

and other related information? 

The docket for this action, identified 

by docket identification (ID) number 

EPA–HQ–OPPT–2019–0578, is available 

at http://www.regulations.gov or at the 

Office of Pollution Prevention and 

Toxics Docket (OPPT Docket), 

Environmental Protection Agency 

Docket Center (EPA/DC), West William 

Jefferson Clinton Bldg., Rm. 3334, 1301 

Constitution Ave. NW, Washington, DC. 

The Public Reading Room is open from 

8:30 a.m. to 4:30 p.m., Monday through 

Friday, excluding legal holidays. The 

telephone number for the Public 

Reading Room is (202) 566–1744, and 

the telephone number for the OPPT 

Docket is (202) 566–0280. 

Please note that due to the public 

health emergency the EPA Docket 

Center (EPA/DC) and Reading Room 

was closed to public visitors on March 

31, 2020. Our EPA/DC staff will 

continue to provide customer service 

via email, phone, and webform. For 

further information on EPA/DC services, 

docket contact information and the 

current status of the EPA/DC and 

Reading Room, please visit https://

www.epa.gov/dockets. 

II. What is the Agency’s authority for 

taking this action? 

TSCA section 5(h)(1) authorizes EPA 

to exempt persons from premanufacture 

notification (PMN) requirements and 

permit them to manufacture (which 

includes import) new chemicals for test 

marketing purposes, if the Agency finds 

that the manufacture, processing, 

distribution in commerce, use, and 

disposal of the chemicals for test 

marketing purposes will not present any 

unreasonable risk of injury to health or 

the environment, including an 

unreasonable risk to a potentially 

exposed or susceptible subpopulation 

identified by the Administrator for the 

specific conditions of use identified in 

the applications. The requirement to 

consider risks to a potentially exposed 

or susceptible subpopulation was added 

to TSCA section 5(h)(1) in 2016. EPA’s 

regulations implementing TSCA section 

5(h)(1) are found at 40 CFR 720.38. 

TSCA section 5(h)(6) requires EPA to 

publish in the Federal Register notice of 

receipt of an application for a TME and 

of the disposition of the application. 

The implementing regulation (40 CFR 

720.38(d)) indicates that EPA will 

publish a notice in the Federal Register 

explaining the reasons for approval or 

denial. 

III. What action is the Agency taking? 

EPA is publishing this document to 

announce TME approvals and denials. 

EPA determined that test marketing the 

new chemicals, under the conditions in 

the TME applications, will not present 

any unreasonable risk of injury to health 

or the environment; the Agency 

approved the TMEs listed in Unit IV. 

For those TMEs for which EPA made 

this approval after TSCA was amended 

in June 2016 by the Lautenberg 

Chemical Safety for the 21st Century 

Act, EPA’s determination included an 

assessment of unreasonable risk to a 

potentially exposed or susceptible 

subpopulation identified by the Agency 

for the specific conditions of use 

identified in the applications. 

EPA has denied the following TMEs 

because EPA was unable to determine 

that test marketing the new chemicals, 

under the conditions in the TME 

applications will not present any 

unreasonable risk of injury to health or 

the environment. For those TMEs for 

which EPA made this denial after TSCA 

was amended in June 2016, EPA’s 

determination included an assessment 

of unreasonable risk to a potentially 

exposed or susceptible subpopulation 

identified by the Agency for the specific 

conditions of use identified in the 

applications. 

TME–13–0004 

Date of Receipt: November 26, 2012. 

Notice of Receipt: December 26, 2012 

(77 FR 76029; FRL–9373–1). 

TME–13–0091 

Date of Receipt: August 22, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

TME–16–0004 

Date of Receipt: November 3, 2015. 

Notice of Receipt: January 12, 2016 

(81 FR 1415; FRL–9940–47). 

TME–16–0005 

Date of Receipt: November 3, 2015. 

Notice of Receipt: January 12, 2016 

(81 FR 1415; FRL–9940–47). 

TME–16–0013 

Date of Receipt: December 15, 2015. 

Notice of Receipt: February 11, 2016 

(81 FR 7337; FRL–9942–09). 

TME–16–0014 

Date of Receipt: December 15, 2015. 

Notice of Receipt: February 11, 2016 

(81 FR 7337; FRL–9942–09). 

TME–16–0015 

Date of Receipt: December 15, 2015. 

Notice of Receipt: February 11, 2016 

(81 FR 7337; FRL–9942–09). 

TME–17–0002 

Date of Receipt: November 17, 2016. 

Notice of Receipt: N/A. 

TME–17–0003 

Date of Receipt: April 5, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 

TME–17–0004 

Date of Receipt: April 5, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 


jbell on DSKJLSW7X2PROD with NOTICES
35500 Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Notices 

TME–17–0005 

Date of Receipt: April 5, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 

TME–17–0006 

Date of Receipt: April 5, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 

TME–17–0007 

Date of Receipt: April 5, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 

TME–17–0008 

Date of Receipt: April 5, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 

TME–17–0009 

Date of Receipt: April 13, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 

TME–17–0010 

Date of Receipt: April 13, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 

TME–17–0011 

Date of Receipt: April 13, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 

TME–17–0012 

Date of Receipt: April 19, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 

TME–17–0013 

Date of Receipt: April 19, 2017. 

Notice of Receipt: July 7, 2017 (82 FR 

31598; FRL–9962–98). 

TME–18–0002 

Date of Receipt: January 26, 2018. 

Notice of Receipt: May 24, 2018 (83 

FR 24110; FRL–9977–48). 

IV. What restrictions apply to the 

approved TMEs? 

The test market time period, 

production volume, number of 

customers, and use must not exceed 

specifications in the applications. All 

other conditions and restrictions 

described in the applications and in this 

document must also be met. 

TME–12–0009 

Date of Receipt: April 18, 2012. 

Notice of Receipt: N/A. 

Applicant: CBI. 

Chemical: (Generic) Alkyl thiol, 

manuf. of, by-products from, distn. 

lights. 

Use: (Generic) Intermediate in the 

production of a commercial product. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–12–0010 

Date of Receipt: April 18, 2012. 

Notice of Receipt: N/A. 

Applicant: CBI. 

Chemical: (Generic) alkyl thiol, 

manuf. of, by-products from, distn. 

lights. 

Use: (Generic) Intermediate in the 

production of a commercial product. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–12–0014 

Date of Receipt: August 27, 2012. 

Notice of Receipt: October 10, 2012 

(77 FR 61600; FRL–9363–2). 

Applicant: Cytec Industries, Inc. 

Chemical: (Generic) Substituted 

heteromonocycle, polymer with 

substituted alkane and substituted 

alkanediol, alkanoic acid substituted 

ester and substituted heteromonocyle 

homopolymer. 

Use: Coating resin. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: Forty-five 

days, commencing on first day of 

commercial manufacture. 

TME–13–0001 

Date of Receipt: October 22, 2012. 

Notice of Receipt: December 14, 2012 

(77 FR 74473; FRL–9338–5). 

Applicant: Cytec Industries, Inc. 

Chemical: (Generic) Alkenoic acid, 

ester with alkylpolyol, polymer with 

disubstituted alkane. 

Use: (Generic) Coating resin. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: Forty-five 

days, commencing on first day of 

commercial manufacture. 

TME–13–0002 

Date of Receipt: November 1, 2012. 

Notice of Receipt: December 26, 2012 

(77 FR 76029; FRL–9373–1). 

Applicant: Cytec Industries, Inc. 

Chemical: (Generic) Alkenenitrile, 

polymer with alkadiene, substituted 

alkyl-terminated, polymers with 

substituted carbonomocycles, alkoxyterminated-substituted alkyl-alkadiene 

polymer, substituted carbomonocycle 

and halogen substituted 

carbomonocycle. 

Use: (Generic) Resin for nondispersive use. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: Forty-five 

days, commencing on first day of 

commercial manufacture. 

TME–13–0003 

Date of Receipt: November 12, 2012. 

Notice of Receipt: December 26, 2012 

(77 FR 76029; FRL–9373–1). 

Applicant: Cytec Industries, Inc. 

Chemical: (Generic) Alkenoic acid, 

reaction product with alkylpolyol, 

polymers with substituted 

heteromonocycle. 

Use: (Generic) Coating resin. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: Forty-five 

days, commencing on first day of 

commercial manufacture. 

TME–13–0007 

Date of Receipt: January 31, 2013. 

Notice of Receipt: March 22, 2013 (78 

FR 17656; FRL–9380–1). 

Applicant: H.B. Fuller Company. 

Chemical: (Generic) Fatty acids, C18- 

unsatd., dimers, polymers with alkane 

acid, 1,6-hexanediol, 1,1′- 

methylenebis[4-isocyanatobenzene] and 

neopentyl glycol. 

Use: (Generic) Industrial adhesive. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0008 

Date of Receipt: February 19, 2013. 

Notice of Receipt: May 15, 2013 (78 

FR 28586; FRL–9383–9). 

Applicant: Cytec Industries, Inc. 

Chemical: (Generic) Alkenoic acid, 

polymer with alkadiene and 

alkenenitrile, substituted alkylterminated, polymers with substituted 

carbomonocycles, alkoxy-terminatedsubstituted alkyl-alkadiene polymer, 

substituted carbomonocycle and 

halogen substituted carbomonocycle. 

Use: (Generic) Resin for nondispersive uses. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: Forty-five 

days, commencing on first day of 

commercial manufacture. 

TME–13–0009 

Date of Receipt: February 19, 2013. 

Notice of Receipt: May 15, 2013 (78 

FR 28586; FRL–9383–9). 

Applicant: CBI. 

Chemical: (Generic) Furandione 

derivative reaction products. 

Use: (Generic) Production aid in 

refinery operations. 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Notices 35501 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0010 

Date of Receipt: May 6, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Alpha-olefins, 

polymers with maleic anhydride, alkyl 

esters. 

Use: (Generic) Crude oil additive. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0053 

Date of Receipt: August 14, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Amine capped 

fatty acid dimer polyamide. 

Use: (Generic) Component in drilling 

fluids; (Generic) Component in resin 

coatings. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0054 

Date of Receipt: August 7, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

oleylalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0055 

Date of Receipt: August 7, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

oleylalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0056 

Date of Receipt: August 7, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

oleylalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0057 

Date of Receipt: August 7, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

oleylalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0058 

Date of Receipt: August 7, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

oleylalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0059 

Date of Receipt: August 7, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

oleylalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0060 

Date of Receipt: August 12, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

cocoalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0061 

Date of Receipt: August 12, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

cocoalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0062 

Date of Receipt: August 12, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

cocoalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0063 

Date of Receipt: August 12, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

cocoalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0064 

Date of Receipt: August 12, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Cycloalkylamino 

cocoalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–13–0065 

Date of Receipt: August 12, 2013. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 


jbell on DSKJLSW7X2PROD with NOTICES
35502 Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Notices 

Chemical: (Generic) Cycloalkylamino 

cocoalkyl alkylamide acid salt. 

Use: (Generic) Inhibitor for oil field 

applications. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–14–0002 

Date of Receipt: January 10, 2014. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Modified 

essential oil. 

Use: (Generic) Highly dispersive use. 

Production Volume: CBI. 

Number of Customers: CBI 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–14–0003 

Date of Receipt: March 7, 2014. 

Notice of Receipt: June 9, 2014 (79 FR 

32939; FRL–9910–70). 

Applicant: CBI. 

Chemical: (Generic) Substituted acid, 

electrophilic aromatic substitution 

products. 

Use: (Generic) Foam suppressant. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–14–0004 

Date of Receipt: July 3, 2014. 

Notice of Receipt: N/A. 

Applicant: Clean Chemistry. 

Chemical: (Generic) Organic peroxide. 

Use: Water clarifying agent, odor 

control agent, bleaching agent, and 

general oxidant for water treatment; 

(Generic) Destructive use in fuel 

production. 

Production Volume: CBI. 

Number of Customers: Six. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–15–0001 

Date of Receipt: November 21, 2014. 

Notice of Receipt: N/A. 

Applicant: Industrial Specialty 

Chemicals. 

Chemical: CBI. 

Use: Paint detackification. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–15–0004 

Date of Receipt: January 8, 2015. 

Notice of Receipt: March 19, 2015 (80 

FR 14374; FRL–9924–61). 

Applicant: CBI. 

Chemical: (Generic) 

Alkylaminopropanamide, N- 

[dialkylamino-propyl], salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–15–0005 

Date of Receipt: January 8, 2015. 

Notice of Receipt: March 19, 2015 (80 

FR 14374; FRL–9924–61). 

Applicant: CBI. 

Chemical: (Generic) 

Alkylaminopropanamide, N- 

[dialkylamino-propyl], salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–15–0006 

Date of Receipt: January 8, 2015. 

Notice of Receipt: March 19, 2015 (80 

FR 14374; FRL–9924–61). 

Applicant: CBI. 

Chemical: (Generic) 

Alkylaminopropanamide, N- 

[dialkylamino-propyl], salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–15–0007 

Date of Receipt: January 8, 2015. 

Notice of Receipt: March 19, 2015 (80 

FR 14374; FRL–9924–61). 

Applicant: CBI. 

Chemical: (Generic) 

Alkylaminopropanamide, N- 

[dialkylamino-propyl], salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–15–0008 

Date of Receipt: March 20, 2015. 

Notice of Receipt: April 22, 2015 (80 

FR 22512; FRL–9926–36). 

Applicant: CBI. 

Chemical: (Generic) Alkyl substituted 

cresol. 

Use: (Generic) Intermediate. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–15–0011 

Date of Receipt: June 24, 2015. 

Notice of Receipt: August 14, 2015 (80 

FR 48855; FRL–9931–82). 

Applicant: CBI. 

Chemical: (Generic) Dialkylamino 

alkylamide salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–15–0012 

Date of Receipt: June 24, 2015. 

Notice of Receipt: August 14, 2015 (80 

FR 48855; FRL–9931–82). 

Applicant: CBI. 

Chemical: (Generic) Dialkylamino 

alkylamide salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–15–0013 

Date of Receipt: June 24, 2015. 

Notice of Receipt: August 14, 2015 (80 

FR 48855; FRL–9931–82). 

Applicant: CBI. 

Chemical: (Generic) Dialkylamino 

alkylamide salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–15–0014 

Date of Receipt: June 24, 2015. 

Notice of Receipt: August 14, 2015 (80 

FR 48855; FRL–9931–82). 

Applicant: CBI. 

Chemical: (Generic) Dialkylamino 

alkylamide salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0001 

Date of Receipt: November 2, 2015. 

Notice of Receipt: January 12, 2016 

(81 FR 1415; FRL–9940–47). 

Applicant: CBI. 

Chemical: (Generic) Dialkylamino 

alkylamide salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Notices 35503 

TME–16–0002 

Date of Receipt: November 2, 2015. 

Notice of Receipt: January 12, 2016 

(81 FR 1415; FRL–9940–47). 

Applicant: CBI. 

Chemical: (Generic) Dialkylamino 

alkylamide salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0003 

Date of Receipt: November 3, 2015. 

Notice of Receipt: January 12, 2016 

(81 FR 1415; FRL–9940–47). 

Applicant: CBI. 

Chemical: (Generic) Beta amino fatty 

ester. 

Use: Chemical Intermediate. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0006 

Date of Receipt: November 3, 2015. 

Notice of Receipt: January 12, 2016 

(81 FR 1415; FRL–9940–47). 

Applicant: CBI. 

Chemical: (Generic) Dialkylamino 

alkylamide. 

Use: Chemical Intermediate. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0007 

Date of Receipt: November 10, 2015. 

Notice of Receipt: N/A. 

Applicant: CBI. 

Chemical: (Generic) Poly 

alkylimidazoline. 

Use: (Generic) Emulsifier. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0008 

Date of Receipt: November 10, 2015. 

Notice of Receipt: N/A. 

Applicant: CBI. 

Chemical: (Generic) Poly 

alkylimidazoline. 

Use: (Generic) Emulsifier. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0009 

Date of Receipt: November 10, 2015. 

Notice of Receipt: N/A. 

Applicant: CBI. 

Chemical: (Generic) Poly 

alkylimidazoline. 

Use: (Generic) Emulsifier. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0010 

Date of Receipt: November 10, 2015. 

Notice of Receipt: N/A. 

Applicant: CBI. 

Chemical: (Generic) Poly 

alkylimidazoline. 

Use: (Generic) Emulsifier. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0011 

Date of Receipt: November 10, 2015. 

Notice of Receipt: N/A. 

Applicant: CBI. 

Chemical: (Generic) Poly 

alkylimidazoline. 

Use: (Generic) Emulsifier. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0012 

Date of Receipt: November 10, 2015. 

Notice of Receipt: N/A. 

Applicant: CBI. 

Chemical: (Generic) Poly 

alkylimidazoline. 

Use: (Generic) Emulsifier. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0016 

Date of Receipt: December 16, 2015. 

Notice of Receipt: February 11, 2016 

(81 FR 7337; FRL–9942–09). 

Applicant: CBI. 

Chemical: (Generic) Dialkylamino 

alkylamide inner salt. 

Use: (Generic) Oil production. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–16–0017 

Date of Receipt: May 25, 2016. 

Notice of Receipt: July 29, 2016 (81 FR 

49976; FRL–9949–63) and September 6, 

2017 (82 FR 42088; FRL–9965–05). 

Applicant: CBI. 

Chemical: (Generic) Modified 

vegetable oil. 

Use: (Generic) Wax. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–18–0001 

Date of Receipt: November 16, 2017. 

Notice of Receipt: May 22, 2018 (83 

FR 23671; FRL–9972–08). 

Applicant: CBI. 

Chemical: (Generic) Renewable 

naptha. 

Use: Component in automotive 

gasoline/transportation fuel for 

consumer use. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

TME–18–0003 

Date of Receipt: July 17, 2018. 

Notice of Receipt: October 22, 2018 

(83 FR 53241; FRL–9985–20). 

Applicant: CBI. 

Chemical: (Generic) Alkylated 

diphenylamines, homopolymers. 

Use: (Generic) Additive. 

Production Volume: CBI. 

Number of Customers: CBI. 

Test Marketing Period: CBI days, 

commencing on first day of commercial 

manufacture. 

EPA may impose restrictions 

considered appropriate by the Agency 

on test marketing activities and may 

modify or revoke this test marketing 

exemption upon receipt of any 

information that indicates the test 

marketing activity may present an 

unreasonable risk of injury to health and 

the environment. The following 

additional restrictions apply to these 

TMEs: A bill of lading accompanying 

each shipment must state that the use of 

the chemical is restricted to that 

approved in the TME. In addition, the 

applicant shall maintain the following 

records for 5 years after the date they are 

created, and shall make them available 

for inspection or copying in accordance 

with TSCA section 11: 

1. Records of the quantity of the TME 

chemical produced and the date of 

manufacture. 

2. Records of dates of the shipments 

to each customer and the quantities 

supplied in each shipment. 

3. Copies of the bill of lading that 

accompanies each shipment of the TME 

chemical. 


jbell on DSKJLSW7X2PROD with NOTICES
35504 Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Notices 

V. What was EPA’s risk assessment for 

these approved TMEs? 

EPA did not identify unreasonable 

health or environmental risks for the 

test market chemicals under the 

intended conditions of use described in 

the TME applications. Therefore, the 

test market activities will not present 

any unreasonable risk of injury to 

human health or the environment, 

including an unreasonable risk to a 

potentially exposed or susceptible 

subpopulation identified by the 

Administrator for the specific 

conditions of use identified in the 

applications. 

VI. Can EPA change its decision on 

these approved TMEs in the future? 

The Agency reserves the right to 

rescind approval or modify the 

conditions and restrictions of an 

exemption upon the receipt or 

evaluation of any information, new or 

existing, that indicates the test 

marketing activities may present an 

unreasonable risk of injury to human 

health or the environment. 

Authority: 15 U.S.C. 2601 et seq. 

Dated: June 11, 2021. 

Madison Le, 

Director, New Chemicals Division, Office of 

Pollution Prevention and Toxics. 

[FR Doc. 2021–14259 Filed 7–2–21; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[FRL–10025–58–OP] 

Request for Nominations for the 

Science Advisory Board 2021 

Scientific and Technological 

Achievement Awards Panel 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Environmental Protection 

Agency (EPA) Science Advisory Board 

(SAB) Staff Office requests public 

nominations of scientific experts to form 

the SAB 2021 Scientific and 

Technological Achievement Awards 

(STAA) Panel. 

DATES: Nominations should be 

submitted by July 27, 2021 per the 

instructions below. 

FOR FURTHER INFORMATION CONTACT: Any 

member of the public wishing further 

information regarding this notice and 

request for nominations may contact Dr. 

Holly Stallworth, Designated Federal 

Officer (DFO), EPA Science Advisory 

Board Staff Office by telephone/voice 

mail (202) 564–2073 or email at 

stallworth.holly@epa.gov. General 

information concerning the EPA SAB 

can be found at the EPA SAB website at 

http://www.epa.gov/sab. 

SUPPLEMENTARY INFORMATION: 

Background: The SAB (42 U.S.C. 

4365) is a chartered Federal Advisory 

Committee that provides independent 

scientific and technical peer review, 

advice, and recommendations to the 

EPA Administrator on the technical 

basis for EPA actions. As a Federal 

Advisory Committee, the SAB conducts 

business in accordance with the Federal 

Advisory Committee Act (FACA) (5 

U.S.C. app. 2) and related regulations. 

The SAB Staff Office is forming the 

2021 STAA Panel, under the auspices of 

the Chartered SAB. The 2021 STAA 

Panel will provide advice through the 

chartered SAB. The SAB and the 2021 

STAA Panel will comply with the 

provisions of FACA and all appropriate 

SAB Staff Office procedural policies. 

The EPA established the STAA in 

1980 to recognize Agency scientists and 

engineers who published their work in 

the peer-reviewed literature. The STAA 

Program is an agency-wide competition 

to promote and recognize scientific and 

technological achievements by EPA 

employees. The STAA program is 

administered and managed by the EPA’s 

Office of Research and Development 

(ORD). Each year the SAB has been 

asked to review the EPA’s STAA 

nominations and make 

recommendations to the Administrator 

for monetary awards. 

Request for Nominations: The SAB 

Staff Office is seeking nominations of 

nationally and internationally 

recognized scientists with demonstrated 

expertise in the following disciplines as 

they relate to human health and the 

environment: Air pollution exposure; 

chemical engineering; civil and 

environmental engineering; decision 

science; ecology; environmental 

economics; groundwater and surface 

water contaminant fate and transport; 

human health effects and risk 

assessment; monitoring and 

measurement methods for air and water; 

risk management; transport and fate of 

contaminants; water quality; and water 

and wastewater treatment processes. 

The SAB Staff Office is especially 

interested in scientists and engineers 

with expertise described above who 

have knowledge and experience in air 

quality; aquatic and ecological 

toxicology; chemical safety; community 

environmental health; dosimetry and 

inhalation toxicology; drinking water; 

ecological modeling; ecological risk 

assessment; ecosystem restoration; 

ecosystem services; energy and the 

environment; epidemiology; green 

chemistry; homeland security; human 

health dosimetry; mechanisms of 

toxicity and carcinogenicity; 

metabolism; statistics; sustainability; 

toxicokinetics; toxicology; waste and 

waste management; and water re-use. 

Process and Deadline for Submitting 

Nominations: Any interested person or 

organization may nominate qualified 

individuals in the areas of expertise 

described above for possible service on 

the 2021 STAA Committee. Individuals 

may self-nominate. Nominations should 

be submitted in electronic format 

(preferred) following the instructions for 

‘‘Nominating Experts to Advisory Panels 

and Ad Hoc Committees Being 

Formed,’’ provided on the SAB website 

(see the ‘‘Nomination of Experts’’ link 

under ‘‘Current Activities’’ at http://

www.epa.gov/sab). To be considered, 

nominations should include the 

information requested below. EPA 

values and welcomes diversity. All 

qualified candidates are encouraged to 

apply regardless of sex, race, disability 

or ethnicity. Nominations should be 

submitted in time to arrive no later than 

July 27, 2021. 

The following information should be 

provided on the nomination form: 

Contact information for the person 

making the nomination; contact 

information for the nominee; and the 

disciplinary and specific areas of 

expertise of the nominee. Nominees will 

be contacted by the SAB Staff Office and 

will be asked to provide a recent 

curriculum vitae and a narrative 

biographical summary that includes: 

Current position, educational 

background; research activities; sources 

of research funding for the last two 

years; and recent service on other 

national advisory committees or 

national professional organizations. 

Persons having questions about the 

nomination procedures, or who are 

unable to submit nominations through 

the SAB website, should contact the 

DFO at the contact information noted 

above. The names and biosketches of 

qualified nominees identified by 

respondents to this Federal Register 

notice, and additional experts identified 

by the SAB Staff Office, will be posted 

in a List of Candidates on the SAB 

website at http://www.epa.gov/sab. 

Public comments on the List of 

Candidates will be accepted for 21 days. 

The public will be requested to provide 

relevant information or other 

documentation on nominees that the 

SAB Staff Office should consider in 

evaluating candidates. 

For the EPA SAB Staff Office a 

balanced review committee includes 


jbell on DSKJLSW7X2PROD with NOTICES